Clinical Trial Update: Raltegravir-based Antiretroviral Versus Maintaining Any Other Antiretroviral Therapy in HIV Mono-infected Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing raltegravir-based antiretroviral therapy to maintaining any other ART in HIV mono-infected patients; completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatty Liver
• HIV Infection
• Nonalcoholic Steatohepatitis

Drugs mentioned

• raltegravir-based antiretroviral therapy (raltegravir)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: HIV, Fatty Liver | Phase 4 | Status: COMPLETED